Optiver Holding’s SpringWorks Therapeutics SWTX Stock Holding History

Optiver Holding’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-477	Closed	-$22.4K	–	2871
2025 Q2	$22.4K	Buy	477 +190	+66%	+$8.45K	﹤0.01%	802
2025 Q1	$12.7K	Buy	+287	New	+$13.2K	﹤0.01%	824

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Optiver Holding's SWTX Position: Q3 2025 in Review

Optiver Holding sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 477 shares — an estimated $22.4K sold.

Optiver Holding first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $22.4K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Optiver Holding reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Optiver Holding sold 477 SpringWorks Therapeutics shares in Q3 2025, an estimated $22.4K.
Optiver Holding first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Optiver Holding's SpringWorks Therapeutics position peaked at $22.4K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Optiver Holding's 13F filing for Q3 2025, filed 10 Nov 2025.